Biomarker discovery by plasma proteomics in familial Brugada Syndrome 

10.2741/4120 ◽  
2013 ◽  
Vol 18 (2) ◽  
pp. 564 ◽  
Author(s):  
Giovanni Cuda
2021 ◽  
Vol 41 (2) ◽  
pp. 77-78
Author(s):  
S.A. Shainker ◽  
R.M. Silver ◽  
A.M. Modest ◽  
M.R. Hacker ◽  
J.L. Hecht ◽  
...  

2020 ◽  
Vol 223 (3) ◽  
pp. 433.e1-433.e14 ◽  
Author(s):  
Scott A. Shainker ◽  
Robert M. Silver ◽  
Anna M. Modest ◽  
Michele R. Hacker ◽  
Jonathan L. Hecht ◽  
...  

Biology ◽  
2014 ◽  
Vol 3 (1) ◽  
pp. 205-219 ◽  
Author(s):  
Vilém Guryča ◽  
Daniel Roeder ◽  
Paolo Piraino ◽  
Jens Lamerz ◽  
Axel Ducret ◽  
...  

2012 ◽  
Vol 11 (4) ◽  
pp. 2103-2113 ◽  
Author(s):  
Cong Zhou ◽  
Kathryn L. Simpson ◽  
Lee J. Lancashire ◽  
Michael J. Walker ◽  
Martin J. Dawson ◽  
...  

2011 ◽  
Vol 32 (24) ◽  
pp. 3638-3644 ◽  
Author(s):  
Francesco Di Girolamo ◽  
Pier Giorgio Righetti

2016 ◽  
Vol 252 ◽  
pp. e72
Author(s):  
I. Izquierdo ◽  
D. De Gonzalo-Calvo ◽  
V. Llorente-Cortes ◽  
I. Rosa ◽  
R. Brugada ◽  
...  

2017 ◽  
Vol 13 (9) ◽  
pp. 942 ◽  
Author(s):  
Philipp E Geyer ◽  
Lesca M Holdt ◽  
Daniel Teupser ◽  
Matthias Mann

2006 ◽  
Vol 5 (11) ◽  
pp. 2167-2174 ◽  
Author(s):  
Tao Liu ◽  
Wei-Jun Qian ◽  
Heather M. Mottaz ◽  
Marina A. Gritsenko ◽  
Angela D. Norbeck ◽  
...  

2018 ◽  
Vol 14 (6) ◽  
pp. 405-423 ◽  
Author(s):  
Liyuan Peng ◽  
David I. Cantor ◽  
Canhua Huang ◽  
Kui Wang ◽  
Mark S. Baker ◽  
...  

The pursuit of novel and effective biomarkers is essential in the struggle against cancer, which is a leading cause of mortality worldwide. Here we discuss the relative advantages and disadvantages of the most frequently used proteomics techniques, concentrating on the latest advances and application of tissue and plasma proteomics for novel cancer biomarker discovery.


Sign in / Sign up

Export Citation Format

Share Document